CA Patent

CA2445528A1 — Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics

Assigned to Janssen Pharmaceuticals Inc · Expires 2002-11-07 · 24y expired

What this patent protects

Treatment of psychotic disorders such as schizophrenia, schizophreniform and schizoaffective disorders comprising co-therapy with an anticonvulsant derivative and atypical antipsychotic.

USPTO Abstract

Treatment of psychotic disorders such as schizophrenia, schizophreniform and schizoaffective disorders comprising co-therapy with an anticonvulsant derivative and atypical antipsychotic.

Drugs covered by this patent

Patent Metadata

Patent number: CA2445528A1
Jurisdiction: CA
Classification: —
Expires: 2002-11-07
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.